| Year |
Citation |
Score |
| 2023 |
Dairo OO, DePaula Oliveira L, Schaffer E, Vidotto T, Mendes AAA, Lu J, Huynh SV, Hicks JL, Sowalsky AG, De Marzo AM, Joshu CE, Hanratty B, Sfanos KS, Isaacs WB, Haffner MC, et al. FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-Genomic Features of Prostate Cancer. Cancer Research Communications. PMID 38112617 DOI: 10.1158/2767-9764.CRC-23-0248 |
0.643 |
|
| 2023 |
Huang FW, Song H, Weinstein HN, Xie J, Cooperberg MR, Hicks J, Mummert L, De Marzo AM, Sfanos KS. Club-like cells in proliferative inflammatory atrophy of the prostate. The Journal of Pathology. 261: 85-95. PMID 37550827 DOI: 10.1002/path.6149 |
0.51 |
|
| 2023 |
Krishnan SN, Thanasupawat T, Arreza L, Wong GW, Sfanos K, Trock B, Arock M, Shah GG, Glogowska A, Ghavami S, Hombach-Klonisch S, Klonisch T. Human C1q Tumor Necrosis Factor 8 (CTRP8) defines a novel tryptase+ mast cell subpopulation in the prostate cancer microenvironment. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 1869: 166681. PMID 36921737 DOI: 10.1016/j.bbadis.2023.166681 |
0.397 |
|
| 2023 |
Vidotto T, Imada EL, Faisal F, Murali S, Mendes AA, Kaur H, Zheng S, Xu J, Schaeffer EM, Isaacs WB, Sfanos KS, Marchionni L, Lotan TL. Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer. Jci Insight. 8. PMID 36752203 DOI: 10.1172/jci.insight.162409 |
0.594 |
|
| 2022 |
Maynard JP, Godwin TN, Lu J, Vidal I, Lotan TL, De Marzo AM, Joshu CE, Sfanos KS. Localization of macrophage subtypes and neutrophils in the prostate tumor microenvironment and their association with prostate cancer racial disparities. The Prostate. PMID 35971807 DOI: 10.1002/pros.24424 |
0.518 |
|
| 2022 |
Peiffer LB, White JR, Jones CB, Slottke RE, Ernst SE, Moran AE, Graff JN, Sfanos KS. Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment with anti-PD-1 (pembrolizumab). Neoplasia (New York, N.Y.). 32: 100822. PMID 35908379 DOI: 10.1016/j.neo.2022.100822 |
0.318 |
|
| 2022 |
Maynard JP, Sfanos KS. P2 purinergic receptor dysregulation in urologic disease. Purinergic Signalling. PMID 35687210 DOI: 10.1007/s11302-022-09875-1 |
0.301 |
|
| 2022 |
Peiffer LB, Hicks J, Sosa RY, De Marzo AM, Sfanos KS, Maynard JP. Modeling Human Prostate Cancer Metastasis in Mice Resection of Subcutaneous Allografts. Frontiers in Oncology. 12: 877536. PMID 35574356 DOI: 10.3389/fonc.2022.877536 |
0.379 |
|
| 2022 |
Ye F, Han X, Shao Y, Lo J, Zhang F, Wang J, Melamed J, Deng FM, Sfanos KS, De Marzo A, Ren G, Wang D, Zhang D, Lee P. Identification of novel biomarkers differentially expressed between African-American and Caucasian-American prostate cancer patients. American Journal of Cancer Research. 12: 1660-1670. PMID 35530298 |
0.373 |
|
| 2022 |
Ozbek B, Ertunc O, Erickson A, Vidal ID, Gomes-Alexandre C, Guner G, Hicks JL, Jones T, Taube JM, Sfanos KS, Yegnasubramanian S, De Marzo AM. Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer. The Prostate. PMID 35188986 DOI: 10.1002/pros.24315 |
0.482 |
|
| 2022 |
Nelson WG, Brawley OW, Isaacs WB, Platz EA, Yegnasubramanian S, Sfanos KS, Lotan TL, De Marzo AM. Health inequity drives disease biology to create disparities in prostate cancer outcomes. The Journal of Clinical Investigation. 132. PMID 35104804 DOI: 10.1172/JCI155031 |
0.679 |
|
| 2021 |
Lopez-Bujanda ZA, Haffner MC, Chaimowitz MG, Chowdhury N, Venturini NJ, Patel RA, Obradovic A, Hansen CS, Jacków J, Maynard JP, Sfanos KS, Abate-Shen C, Bieberich CJ, Hurley PJ, Selby MJ, et al. Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression. Nature Cancer. 2: 803-818. PMID 35122025 DOI: 10.1038/s43018-021-00227-3 |
0.421 |
|
| 2021 |
Hong LK, Kadkol S, Sverdlov M, Kastrati I, Elhodaky M, Deaton R, Sfanos KS, Wang H, Liu L, Diamond AM. Loss of SELENOF Induces the Transformed Phenotype in Human Immortalized Prostate Epithelial Cells. International Journal of Molecular Sciences. 22. PMID 34769469 DOI: 10.3390/ijms222112040 |
0.572 |
|
| 2021 |
Sfanos KS. Immune cell infiltrates and prognosis in localized prostate cancer. The Journal of Pathology. PMID 34694014 DOI: 10.1002/path.5817 |
0.439 |
|
| 2021 |
Maynard JP, Lu J, Vidal I, Hicks J, Mummert L, Ali T, Kempski R, Carter AM, Sosa RY, Peiffer LB, Joshu CE, Lotan TL, De Marzo AM, Sfanos KS. P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer. The Journal of Pathology. PMID 34652816 DOI: 10.1002/path.5815 |
0.509 |
|
| 2021 |
Shrestha E, Coulter JB, Guzman W, Ozbek B, Hess MM, Mummert L, Ernst SE, Maynard JP, Meeker AK, Heaphy CM, Haffner MC, De Marzo AM, Sfanos KS. Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34341114 DOI: 10.1073/pnas.2018976118 |
0.544 |
|
| 2021 |
Vidal I, Zheng Q, Hicks JL, Chen J, Platz EA, Trock BJ, Kulac I, Baena-Del Valle JA, Sfanos KS, Ernst S, Jones T, Maynard JP, Glavaris SA, Nelson WG, Yegnasubramanian S, et al. GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States. Plos One. 16: e0241934. PMID 34191807 DOI: 10.1371/journal.pone.0241934 |
0.526 |
|
| 2021 |
Markowski MC, Sfanos KS. The interplay of microbiota and hormone regulation in men with prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 34007013 DOI: 10.1038/s41391-021-00385-6 |
0.536 |
|
| 2021 |
Guest C, Harris R, Sfanos KS, Shrestha E, Partin AW, Trock B, Mangold L, Bader R, Kozak A, Mclean S, Simons J, Soule H, Johnson T, Lee WY, Gao Q, et al. Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer. Plos One. 16: e0245530. PMID 33596212 DOI: 10.1371/journal.pone.0245530 |
0.495 |
|
| 2021 |
Langston ME, Sfanos KS, Khan S, Nguyen TQ, De Marzo AM, Platz EA, Sutcliffe S. Why Do Epidemiologic Studies Find an Inverse Association Between Intraprostatic Inflammation and Prostate Cancer: A Possible Role for Colliding Bias? Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 30: 255-259. PMID 33547143 DOI: 10.1158/1055-9965.EPI-20-1009 |
0.577 |
|
| 2020 |
Joshu CE, Heaphy CM, Barber JR, Lu J, Zarinshenas R, Davis C, Han M, Lotan TL, Sfanos KS, De Marzo AM, Meeker AK, Platz EA. Obesity is associated with shorter telomere length in prostate stromal cells in men with aggressive prostate cancer. Cancer Prevention Research (Philadelphia, Pa.). PMID 33355185 DOI: 10.1158/1940-6207.CAPR-20-0250 |
0.445 |
|
| 2020 |
Hempel Sullivan H, Maynard JP, Heaphy CM, Lu J, De Marzo AM, Lotan TL, Joshu CE, Sfanos KS. Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomes. The Journal of Pathology. PMID 33338262 DOI: 10.1002/path.5606 |
0.388 |
|
| 2020 |
Liu W, Zheng SL, Na R, Wei L, Sun J, Gallagher J, Wei J, Resurreccion WK, Ernst S, Sfanos KS, Isaacs WB, Xu J. Distinct Genomic Alterations in Prostate Tumors Derived from African American Men. Molecular Cancer Research : McR. PMID 33115829 DOI: 10.1158/1541-7786.MCR-20-0648 |
0.585 |
|
| 2020 |
Wise DR, Schneider JA, Armenia J, Febles VA, McLaughlin B, Brennan R, Thoren KL, Abida W, Sfanos KS, De Marzo AM, Yegnasubramanian S, Fox JJ, Haas M, Heath H, Kagey MH, et al. Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer. Jco Precision Oncology. 4. PMID 33015525 DOI: 10.1200/PO.20.00097 |
0.517 |
|
| 2020 |
de Bono JS, Guo C, Gurel B, De Marzo AM, Sfanos KS, Mani RS, Gil J, Drake CG, Alimonti A. Prostate carcinogenesis: inflammatory storms. Nature Reviews. Cancer. PMID 32546840 DOI: 10.1038/S41568-020-0267-9 |
0.61 |
|
| 2020 |
Su ZT, Zenilman JM, Sfanos KS, Herati AS. Management of Chronic Bacterial Prostatitis. Current Urology Reports. 21: 29. PMID 32488742 DOI: 10.1007/S11934-020-00978-Z |
0.559 |
|
| 2020 |
Hempel Sullivan H, Heaphy CM, Kulac I, Cuka N, Lu J, Barber JR, De Marzo AM, Lotan TL, Joshu CE, Sfanos KS. High Extra-tumoral Mast Cell Counts are Associated with a Higher Risk of Adverse Prostate Cancer Outcomes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31932412 DOI: 10.1158/1055-9965.Epi-19-0962 |
0.42 |
|
| 2020 |
Heaphy CM, Joshu CE, Barber JR, Davis C, Zarinshenas R, De Marzo AM, Lotan TL, Sfanos KS, Meeker AK, Platz EA. Racial difference in prostate cancer cell telomere lengths in men with higher-grade prostate cancer: a clue to the racial disparity in prostate cancer outcomes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31915143 DOI: 10.1158/1055-9965.Epi-19-1462 |
0.605 |
|
| 2020 |
Hamilton AS, Gomez S, Wu X, Ward K, Bondy M, Cress R, Beebe-Dimmer J, Pawlish K, Park J, Cheng I, Stroup A, Sellers T, Gundell S, Demarzo A, Modjeski D, ... ... Sfanos K, et al. Abstract IA22: A comprehensive and integrated approach to identify factors associated with aggressive prostate cancer in African-Americans: The RESPOND Study Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-Ia22 |
0.553 |
|
| 2020 |
Hamilton AS, Gomez S, Wu X, Ward K, Bondy M, Cress R, Beebe-Dimmer J, Pawlish K, Park J, Cheng I, Stroup A, Sellers T, Gundell S, Demarzo A, Modjeski D, ... ... Sfanos K, et al. Abstract PR06: Research on prostate cancer in men of African ancestry: Defining the roles of genetics, tumor markers, and social stress Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-Pr06 |
0.507 |
|
| 2019 |
Maynard JP, Ertunc O, Kulac I, Baena Del Valle JA, De Marzo AM, Sfanos KS. Interleukin-8 Expression is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer. Molecular Cancer Research : McR. PMID 31604846 DOI: 10.1158/1541-7786.Mcr-19-0595 |
0.411 |
|
| 2019 |
Porter CM, Haffner MC, Kulac I, Maynard JP, Baena-Del Valle JA, Isaacs WB, Yegnasubramanian S, De Marzo AM, Sfanos KS. Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate Carcinogenesis. The American Journal of Pathology. PMID 31499027 DOI: 10.1016/J.Ajpath.2019.07.016 |
0.681 |
|
| 2019 |
Peiffer LB, Poynton SL, Ernst SE, Hicks JL, De Marzo AM, Sfanos KS. Inflammation-associated pathologies in a case of prostate schistosomiasis: Implications for a causal role in prostate carcinogenesis. The Prostate. PMID 31212384 DOI: 10.1002/Pros.23841 |
0.595 |
|
| 2019 |
Kaur HB, Lu J, Guedes LB, Maldonado L, Reitz L, Barber JR, De Marzo AM, Tomlins SA, Sfanos KS, Eisenberger M, Schaeffer EM, Joshu CE, Lotan TL. TP53 missense mutation is associated with increased tumor-infiltrating T-cells in primary prostate Cancer. Human Pathology. PMID 30851334 DOI: 10.1016/J.Humpath.2019.02.006 |
0.388 |
|
| 2019 |
Sfanos KS, Joshu CE. IBD as a risk factor for prostate cancer: what is the link? Nature Reviews. Urology. PMID 30742047 DOI: 10.1038/S41585-019-0157-7 |
0.624 |
|
| 2019 |
Markowski MC, Boorjian SA, Burton JP, Hahn NM, Ingersoll MA, Vareki SM, Pal SK, Sfanos KS. The Microbiome and Genitourinary Cancer: A Collaborative Review. European Urology. PMID 30655087 DOI: 10.1016/J.Eururo.2018.12.043 |
0.492 |
|
| 2018 |
Yu SH, Maynard JP, Vaghasia AM, De Marzo AM, Drake CG, Sfanos KS. A role for paracrine interleukin-6 signaling in the tumor microenvironment in prostate tumor growth. The Prostate. PMID 30345534 DOI: 10.1002/Pros.23726 |
0.525 |
|
| 2018 |
Trabzonlu L, Kulac I, Zheng Q, Hicks JL, Haffner MC, Nelson WG, Sfanos KS, Ertunc O, Lotan TL, Heaphy CM, Meeker AK, Yegnasubramanian S, De Marzo AM. Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities. Cold Spring Harbor Perspectives in Medicine. PMID 30082453 DOI: 10.1101/Cshperspect.A030403 |
0.581 |
|
| 2018 |
DuPre NC, Flavin R, Sfanos KS, Unger RH, To S, Gazeeva E, Fiorentino M, De Marzo AM, Rider JR, Mucci LA. Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors. The Prostate. PMID 30009541 DOI: 10.1002/Pros.23692 |
0.537 |
|
| 2018 |
Górski A, Jończyk-Matysiak E, Łusiak-Szelachowska M, Międzybrodzki R, Weber-Dąbrowska B, Borysowski J, Letkiewicz S, Bagińska N, Sfanos KS. Phage Therapy in Prostatitis: Recent Prospects. Frontiers in Microbiology. 9: 1434. PMID 30008710 DOI: 10.3389/Fmicb.2018.01434 |
0.613 |
|
| 2018 |
Sfanos KS, Markowski MC, Peiffer LB, Ernst SE, White JR, Pienta KJ, Antonarakis ES, Ross AE. Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate Cancer and Prostatic Diseases. PMID 29988102 DOI: 10.1038/S41391-018-0061-X |
0.44 |
|
| 2018 |
Kaur HB, Guedes LB, Lu J, Maldonado L, Reitz L, Barber JR, De Marzo AM, Tosoian JJ, Tomlins SA, Schaeffer EM, Joshu CE, Sfanos KS, Lotan TL. Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 29849114 DOI: 10.1038/S41379-018-0083-X |
0.397 |
|
| 2018 |
Porter CM, Shrestha E, Peiffer LB, Sfanos KS. The microbiome in prostate inflammation and prostate cancer. Prostate Cancer and Prostatic Diseases. PMID 29795140 DOI: 10.1038/S41391-018-0041-1 |
0.646 |
|
| 2018 |
Sfanos KS. Targeting Toll-like Receptors in Cancer Prevention. Cancer Prevention Research (Philadelphia, Pa.). PMID 29661854 DOI: 10.1158/1940-6207.Capr-18-0079 |
0.311 |
|
| 2018 |
Maynard JP, Marzo AMD, Sfanos KS. Abstract B54: The inflammatory microenvironment in prostate cancer racial disparities Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-B54 |
0.462 |
|
| 2018 |
Shrestha E, Sfanos KS. Abstract 5136: Development of an RNA hybridization technique for the in situ visualization of bacteria in cancer tissues Cancer Research. 78: 5136-5136. DOI: 10.1158/1538-7445.Am2018-5136 |
0.476 |
|
| 2018 |
Maynard JP, Ertunc O, Marzo AMD, Sfanos KS. Abstract 5069: Inflammatory cytokine localization in the prostate tumor microenvironment and their association with prostate cancer racial disparities Cancer Research. 78: 5069-5069. DOI: 10.1158/1538-7445.Am2018-5069 |
0.463 |
|
| 2018 |
Ernst SE, Markowski MC, Gupta A, Wheelan SJ, Carter HB, Partin AW, Sears CL, Sfanos KS. Abstract 129: Biobanking and feasibility considerations for prostate cancer gastrointestinal microbiome studies Cancer Research. 78: 129-129. DOI: 10.1158/1538-7445.Am2018-129 |
0.624 |
|
| 2017 |
Sfanos KS, Yegnasubramanian S, Nelson WG, De Marzo AM. The inflammatory microenvironment and microbiome in prostate cancer development. Nature Reviews. Urology. PMID 29089606 DOI: 10.1038/Nrurol.2017.167 |
0.653 |
|
| 2017 |
Shrestha E, White JR, Yu SH, Kulac I, Ertunc O, De Marzo AM, Yegnasubramanian S, Mangold LA, Partin AW, Sfanos KS. Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer. The Journal of Urology. PMID 28797714 DOI: 10.1016/J.Juro.2017.08.001 |
0.639 |
|
| 2017 |
Huang FW, Mosquera JM, Garofalo A, Oh C, Baco M, Amin-Mansour A, Rabasha B, Bahl S, Mullane SA, Robinson BD, Aldubayan S, Khani F, Karir B, Kim E, Chimene-Weiss J, ... ... Sfanos K, et al. Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations. Cancer Discovery. PMID 28515055 DOI: 10.1158/2159-8290.Cd-16-0960 |
0.612 |
|
| 2016 |
Puhr M, De Marzo A, Isaacs W, Lucia MS, Sfanos K, Yegnasubramanian S, Culig Z. Inflammation, Microbiota, and Prostate Cancer. European Urology Focus. 2: 374-382. PMID 28723469 DOI: 10.1016/J.Euf.2016.08.010 |
0.715 |
|
| 2016 |
Hempel HA, Cuka NS, Kulac I, Barber JR, Cornish TC, Platz EA, De Marzo AM, Sfanos KS. Low Intratumoral Mast Cells Are Associated With a Higher Risk of Prostate Cancer Recurrence. The Prostate. PMID 27868214 DOI: 10.1002/Pros.23280 |
0.614 |
|
| 2016 |
Miyahira AK, Roychowdhury S, Goswami S, Ippolito JE, Priceman SJ, Pritchard CC, Sfanos KS, Subudhi SK, Simons JW, Pienta KJ, Soule HR. Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting. The Prostate. PMID 27679977 DOI: 10.1002/Pros.23260 |
0.633 |
|
| 2016 |
Hempel HA, Kulac I, Cuka NS, Cornish TC, Marzo AMD, Sfanos KS. Abstract C73: A relationship between mast cells and the racial disparity of prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-C73 |
0.613 |
|
| 2015 |
Yu SH, Zheng Q, Esopi D, Macgregor-Das A, Luo J, Antonarakis ES, Drake CG, Vessella R, Morrissey C, De Marzo AM, Sfanos KS. A Paracrine Role for IL-6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells. Cancer Immunology Research. PMID 26048576 DOI: 10.1158/2326-6066.Cir-15-0013 |
0.505 |
|
| 2015 |
Sfanos KS, Canene-Adams K, Hempel H, Yu SH, Simons BW, Schaeffer AJ, Schaeffer EM, Nelson WG, De Marzo AM. Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites. Cancer Prevention Research (Philadelphia, Pa.). 8: 683-92. PMID 25990088 DOI: 10.1158/1940-6207.Capr-15-0090 |
0.561 |
|
| 2015 |
Liang J, Li Y, Daniels G, Sfanos K, De Marzo A, Wei J, Li X, Chen W, Wang J, Zhong X, Melamed J, Zhao J, Lee P. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a. Molecular Cancer Research : McR. 13: 681-8. PMID 25587085 DOI: 10.1158/1541-7786.Mcr-14-0503 |
0.382 |
|
| 2015 |
Porter CM, Yu S, Sfanos K. Abstract A71: Metagenomic studies of bacterial agents in prostate cancer racial disparities Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-A71 |
0.65 |
|
| 2015 |
Hempel HA, Kulac I, Cuka NS, Cornish TC, Marzo AMD, Sfanos KS. Abstract A70: Mast cells in prostate cancer race disparities: Are the minutemen of the microenvironment the key? Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-A70 |
0.647 |
|
| 2015 |
Hubbard GK, Yu S, Shinohara DB, Vaghasia A, Nelson WG, Yegnasubramanian S, Marzo AMD, Sfanos KS. Abstract 5021: Histopathologic and gene expression analysis in mouse models of long-term chronic prostatic inflammation using human prostate cancer-derived bacterial isolates Immunology. 75: 5021-5021. DOI: 10.1158/1538-7445.Am2015-5021 |
0.61 |
|
| 2015 |
Hempel H, Kulac I, Cuka NS, Cornish TC, Platz EA, DeMarzo AM, Sfanos KS. Abstract 2342: Characterization of inflammatory markers and mast cells in association with prostate cancer Cancer Research. 75: 2342-2342. DOI: 10.1158/1538-7445.Am2015-2342 |
0.607 |
|
| 2014 |
Sfanos KS, Hempel HA, De Marzo AM. The role of inflammation in prostate cancer. Advances in Experimental Medicine and Biology. 816: 153-81. PMID 24818723 DOI: 10.1007/978-3-0348-0837-8_7 |
0.621 |
|
| 2014 |
Sutcliffe S, De Marzo AM, Sfanos KS, Laurence M. MSMB variation and prostate cancer risk: clues towards a possible fungal etiology. The Prostate. 74: 569-78. PMID 24464504 DOI: 10.1002/Pros.22778 |
0.629 |
|
| 2014 |
Darshan M, Zheng Q, Fedor HL, Wyhs N, Yegnasubramanian S, Lee P, Melamed J, Netto GJ, Trock BJ, De Marzo AM, Sfanos KS. Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network. The Prostate. 74: 61-9. PMID 24115205 DOI: 10.1002/Pros.22730 |
0.613 |
|
| 2014 |
Yu S, Zheng Q, Luo J, Macgregor-Das A, Antonarakis ES, Marzo AMD, Sfanos K. Abstract 1648: Interleukin-6 expression is restricted to the prostate stromal compartment and is not expressed by either primary or metastatic prostatic adenocarcinoma cells Cancer Research. 74: 1648-1648. DOI: 10.1158/1538-7445.Am2014-1648 |
0.566 |
|
| 2013 |
Sfanos KS, Isaacs WB, De Marzo AM. Infections and inflammation in prostate cancer. American Journal of Clinical and Experimental Urology. 1: 3-11. PMID 25110720 |
0.701 |
|
| 2013 |
Mak TN, Sfanos KS, Brüggemann H. Draft Genome Sequences of Two Strains of Propionibacterium acnes Isolated from Radical Prostatectomy Specimens. Genome Announcements. 1. PMID 24356837 DOI: 10.1128/Genomea.01071-13 |
0.397 |
|
| 2013 |
Canene-Adams K, Sfanos KS, Liang CT, Yegnasubramanian S, Nelson WG, Brayton C, De Marzo AM. Dietary chemoprevention of PhIP induced carcinogenesis in male Fischer 344 rats with tomato and broccoli. Plos One. 8: e79842. PMID 24312188 DOI: 10.1371/Journal.Pone.0079842 |
0.384 |
|
| 2013 |
Mak TN, Schmid M, Brzuszkiewicz E, Zeng G, Meyer R, Sfanos KS, Brinkmann V, Meyer TF, Brüggemann H. Comparative genomics reveals distinct host-interacting traits of three major human-associated propionibacteria. Bmc Genomics. 14: 640. PMID 24053623 DOI: 10.1186/1471-2164-14-640 |
0.383 |
|
| 2013 |
Fischer N, Mak TN, Shinohara DB, Sfanos KS, Meyer TF, Brüggemann H. Deciphering the intracellular fate of Propionibacterium acnes in macrophages. Biomed Research International. 2013: 603046. PMID 23862148 DOI: 10.1155/2013/603046 |
0.438 |
|
| 2013 |
Hempel HA, Burns KH, De Marzo AM, Sfanos KS. Infection of Xenotransplanted Human Cell Lines by Murine Retroviruses: A Lesson Brought Back to Light by XMRV. Frontiers in Oncology. 3: 156. PMID 23785669 DOI: 10.3389/Fonc.2013.00156 |
0.31 |
|
| 2013 |
Shinohara DB, Vaghasia AM, Yu SH, Mak TN, Brüggemann H, Nelson WG, De Marzo AM, Yegnasubramanian S, Sfanos KS. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. The Prostate. 73: 1007-15. PMID 23389852 DOI: 10.1002/Pros.22648 |
0.651 |
|
| 2013 |
Mak TN, Yu SH, De Marzo AM, Brüggemann H, Sfanos KS. Multilocus sequence typing (MLST) analysis of Propionibacterium acnes isolates from radical prostatectomy specimens. The Prostate. 73: 770-7. PMID 23184509 DOI: 10.1002/Pros.22621 |
0.536 |
|
| 2013 |
Shinohara DB, Vaghasia A, Yu S, Nelson WG, Marzo AMD, Yegnasubramanian S, Sfanos KS. Abstract 312: A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Cancer Research. 73: 312-312. DOI: 10.1158/1538-7445.Am2013-312 |
0.643 |
|
| 2012 |
Mak TN, Fischer N, Laube B, Brinkmann V, Metruccio MM, Sfanos KS, Mollenkopf HJ, Meyer TF, Brüggemann H. Propionibacterium acnes host cell tropism contributes to vimentin-mediated invasion and induction of inflammation. Cellular Microbiology. 14: 1720-33. PMID 22759266 DOI: 10.1111/J.1462-5822.2012.01833.X |
0.531 |
|
| 2012 |
Sfanos KS, Aloia AL, De Marzo AM, Rein A. XMRV and prostate cancer--a 'final' perspective. Nature Reviews. Urology. 9: 111-8. PMID 22231291 DOI: 10.1038/Nrurol.2011.225 |
0.632 |
|
| 2012 |
Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology. 60: 199-215. PMID 22212087 DOI: 10.1111/J.1365-2559.2011.04033.X |
0.593 |
|
| 2011 |
Sfanos KS, Aloia AL, Hicks JL, Esopi DM, Steranka JP, Shao W, Sanchez-Martinez S, Yegnasubramanian S, Burns KH, Rein A, de Marzo AM. Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines Plos One. 6. PMID 21698104 DOI: 10.1371/Journal.Pone.0020874 |
0.473 |
|
| 2011 |
Sfanos KS, Isaacs JT. The "infectious" nature of human prostate cancer: a cautionary note. Oncotarget. 2: 281-3. PMID 21521904 DOI: 10.18632/Oncotarget.267 |
0.46 |
|
| 2010 |
Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, De Marzo AM, Rein A. XMRV: a new virus in prostate cancer? Cancer Research. 70: 10028-33. PMID 20966126 DOI: 10.1158/0008-5472.Can-10-2837 |
0.593 |
|
| 2009 |
Sfanos KS, Bruno TC, Meeker AK, De Marzo AM, Isaacs WB, Drake CG. Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+. The Prostate. 69: 1694-703. PMID 19670224 DOI: 10.1002/Pros.21020 |
0.601 |
|
| 2009 |
Sfanos KS, Wilson BA, De Marzo AM, Isaacs WB. Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 106: 3443-8. PMID 19202053 DOI: 10.1073/Pnas.0810473106 |
0.711 |
|
| 2008 |
Sfanos KS, Isaacs WB. An evaluation of PCR primer sets used for detection of Propionibacterium acnes in prostate tissue samples. The Prostate. 68: 1492-5. PMID 18651578 DOI: 10.1002/Pros.20820 |
0.595 |
|
| 2008 |
Sfanos KS, Bruno TC, Maris CH, Xu L, Thoburn CJ, DeMarzo AM, Meeker AK, Isaacs WB, Drake CG. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3254-61. PMID 18519750 DOI: 10.1158/1078-0432.Ccr-07-5164 |
0.704 |
|
| 2008 |
Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. The Prostate. 68: 306-20. PMID 18163428 DOI: 10.1002/Pros.20680 |
0.722 |
|
| 2005 |
Sfanos K, Harmody D, Dang P, Ledger A, Pomponi S, McCarthy P, Lopez J. A molecular systematic survey of cultured microbial associates of deep-water marine invertebrates. Systematic and Applied Microbiology. 28: 242-64. PMID 15900971 DOI: 10.1016/J.Syapm.2004.12.002 |
0.637 |
|
| 2005 |
Gunasekera AS, Sfanos KS, Harmody DK, Pomponi SA, McCarthy PJ, Lopez JV. HBMMD: an enhanced database of the microorganisms associated with deeper water marine invertebrates. Applied Microbiology and Biotechnology. 66: 373-6. PMID 15599519 DOI: 10.1007/S00253-004-1763-7 |
0.628 |
|
| Show low-probability matches. |